While BNT113 failed to improve progression-free survival in patients with a type of head and neck cancer during a Phase 3 ...
Syndax Pharmaceuticals will no longer test Niktimvo for idiopathic pulmonary fibrosis, but the company’s work to expand the ...
Biodexa Pharmaceuticals PLC (Nasdaq: BDRX) (“Biodexa” or “the Company”), a clinical stage biopharmaceutical company ...
(NYSE American:NNVC) (the "Company"), a clinical stage leader developing antiviral drugs that viruses cannot escape, said ...
Ho's appointment adds more than 20 years of oncology, biopharma and capital markets experience, including senior roles in ...
Enodia Therapeutics, a biotechnology company developing novel small-molecule therapies for targeted protein degradation at ...
(Latus), a biotechnology company engineering gene therapies at scale, today announced that four abstracts have been accepted ...
(NASDAQ:ENTA), a clinical stage biotechnology company dedicated to creating novel, small molecule drugs for viral infections ...
InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and ...
Evergreen Therapeutics, Inc., a Maryland based clinical-stage biotechnology company leveraging artificial intelligence (AI) ...
ATYR0101 is currently undergoing IND-enabling studies and expects to be advanced into the clinic in 2027. ATYR0101 is a ...
Cyted Health will present clinical validation data from DETECT-ME, a prospective, 18-site U.S. study of the EndoSign ® ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results